Business Description
Protagonist Therapeutics is a US-based drug discovery and development company focused on creating novel treatments for blood disorders, skin conditions, and obesity. Its most advanced programs include Rusfertide, an injectable treatment in late-stage trials for the rare blood disorder polycythemia vera, and Icotyde, an oral peptide therapy for moderate-to-severe plaque psoriasis. The company has several additional candidates in earlier stages of development targeting conditions such as atopic dermatitis, asthma, and obesity. Founded in 2006 and based in Newark, California, Protagonist has built its pipeline around peptide-based medicines designed to mimic or block naturally occurring proteins in the body.
